Health Trial data underpins FDA approval of omalizumab for food allergy Posted on February 17, 2024 by miyuru Credit: Unsplash/CC0 Public Domain Today’s Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of….